Early research (Phase 1)Study completedNCT00002353
What this trial is testing
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
Who this might be right for
HIV Infections
United Biomedical